Sequana Medical Valuation Multiples

Sequana Medical Overview

About Sequana Medical

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Founded

2006

HQ

Employees

48

Website

sequanamedical.com

Sectors

Medical DevicesHealthTech

Financials (LTM)

Revenue: $2M

EBITDA: ($23M)

EV

$84M

Valuation Multiples

Multiples.vc

Start free trial

Sequana Medical Financials

Sequana Medical reported last 12-month revenue of $2M and negative EBITDA of ($23M).

In the same LTM period, Sequana Medical generated ($23M) in EBITDA losses and had net loss of ($755K).

Sequana Medical P&L

In the most recent fiscal year, Sequana Medical reported revenue of $122K and EBITDA of ($47M).

Sequana Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

Sequana Medical Stock Performance

Sequana Medical has current market cap of $45M, and enterprise value of $84M.

Sequana Medical's stock price is $0.58.

Sequana Medical Valuation Multiples

Sequana Medical trades at 36.0x EV/Revenue multiple, and (3.6x) EV/EBITDA.

Sequana Medical Financial Valuation Multiples

As of April 8, 2026, Sequana Medical has market cap of $45M and EV of $84M.

Equity research analysts estimate Sequana Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Sequana Medical has a P/E ratio of (59.3x).

Sequana Medical Margins & Growth Rates

Sequana Medical's revenue in the last 12 month grew by 351%.

Sequana Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.

Sequana Medical's rule of 40 is 512% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Sequana Medical's rule of X is 1843% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Sequana Medical Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Sequana Medical M&A Activity

Sequana Medical acquired XXX companies to date.

Last acquisition by Sequana Medical was on XXXXXXXX, XXXXX. Sequana Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Sequana Medical Investment Activity

Sequana Medical invested in XXX companies to date.

Sequana Medical made its latest investment on XXXXXXXX, XXXXX. Sequana Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).